Cover Image
市場調查報告書

次世代定序 (NGS) 服務的全球市場的預測 ∼2022年:標的、RNA-Seq、Exome、De Novo

Next-Generation Sequencing (NGS) Services Market by Type (Targeted, RNA-Seq, Exome, De Novo), Technology (Sequencing by Synthesis, Ion semiconductor, SMRT, Nanopore), & Application (Diagnostics, Oncology, Drug Discovery, Agriculture) - Forecasts to 2022

出版商 MarketsandMarkets 商品編碼 549086
出版日期 內容資訊 英文 159 Pages
訂單完成後即時交付
價格
Back to Top
次世代定序 (NGS) 服務的全球市場的預測 ∼2022年:標的、RNA-Seq、Exome、De Novo Next-Generation Sequencing (NGS) Services Market by Type (Targeted, RNA-Seq, Exome, De Novo), Technology (Sequencing by Synthesis, Ion semiconductor, SMRT, Nanopore), & Application (Diagnostics, Oncology, Drug Discovery, Agriculture) - Forecasts to 2022
出版日期: 2017年08月24日 內容資訊: 英文 159 Pages
簡介

全球次世代定序 (NGS) 服務的市場在預測期間內,預計以21.0%的年複合成長率發展,從2017年的10億5920萬美元,成長到2022年的27億4860萬美元的規模。定序價格低,定序基礎設施的高成本性,可有效率地製作、分析NGS樣品的技術人員的需求,定序領域的技術發展等要素,促進該市場的成長。

本報告提供全球次世代定序 (NGS) 服務的市場調查,市場定義和概要,市場成長的影響因素及市場機會分析,各技術、服務類型、用途、終端用戶、地區/主要國家趨勢與市場規模的變化與預測,競爭環境,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 市場概要
  • 市場成果、預測:各類型
  • 各市場成果、地區、技術
  • 各用途市場
  • 市場成果、預測:各終端用戶
  • 地區概要

第5章 市場概要

  • 簡介
  • 市場動態
    • 成長推動因素
    • 阻礙成長要素
    • 市場機會
    • 課題

第6章 市場分析:各技術

  • 簡介
  • 合成定序
  • 離子半導體定序
  • 單分子即時定序
  • 奈米孔洞定序

第7章 市場分析:各服務形式

  • 簡介
  • 標的再定序、自訂遺傳基因面板
  • RNA-SEQ
  • DE NOVO定序
  • EXOME 定序
  • CHIP-SEQ
  • 全基因測序
  • METHYL-SEQ
  • 其他

第8章 市場分析:各用途

  • 簡介
  • 診斷
    • 癌症
    • 感染疾病
    • 稀少遺傳性疾病
    • 生殖相關
    • 其他
  • 藥物研發
  • 生物標記發現
  • 農業、動物研究
  • 其他

第9章 市場分析:各終端用戶

  • 簡介
  • 學術&政府機關、研究中心
  • 醫院、診療所
  • 醫藥品、生物科技企業
  • 其他

第10章 地區分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他
  • 其他地區

第11章 競爭環境

  • 簡介
  • 市場排行榜
  • 競爭領導基準
  • 產品系列
  • 產業策略

第12章 企業簡介

  • 簡介
  • BGI
  • ILLUMINA, INC.
  • PERKINELMER, INC.
  • EUROFINS SCIENTIFIC SE
  • GATC BIOTECH AG
  • MACROGEN, INC.
  • QIAGEN N.V.
  • GENOTYPIC TECHNOLOGY PVT. LTD.
  • GENEWIZ, INC.
  • DNA LINK, INC.
  • TaKaRa BIO
  • SCIGENOM LABS PVT. LTD
  • NOVOGENE CORPORATION
  • PERSONALIS, INC.
  • LGC LIMITED

第13章 附錄

目錄
Product Code: BT 5526

"Global next-generation sequencing (NGS) services market projected to grow at a CAGR of 21.0%"

The global next-generation sequencing (NGS) services market is expected to reach USD 2,748.6 million by 2022 from USD 1,059.2 million in 2017; growing at a CAGR of 21.0% during the forecast period. Factors such as declining price of sequencing, the high cost of sequencing infrastructure, the need for skilled professionals for efficient NGS sample preparation and analysis, and technological advancements in the field of sequencing are driving the growth of this market. However, installation of in-house sequencing facilities in hospitals and universities is expected to limit the optimal market growth for NGS services during the forecast period

"Targeted resequencing & custom gene panels are expected to grow at the highest CAGR during 2017 to 2022"

By type, the global NGS services market covers targeted resequencing & custom gene panels, RNA-Seq, de novo sequencing, exome sequencing, CHiP-Seq, whole-genome sequencing, methyl-seq, and other services. The targeted resequencing & custom gene panels segment is expected to grow at the highest CAGR during 2017 to 2022. Targeted sequencing/gene panels allow researchers to focus on the subset of genes or region, which reduces the time consumed for sequencing, the cost of sequencing, and simplifies data analysis.

"Sequencing by synthesis technology to dominate the global NGS services market during the forecast period"

By technology, the NGS services market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time sequencing, and nanopore sequencing. The SBS segment is estimated to account for the largest share of the NGS services market in 2017. The introduction of technologically advanced SBS platforms and decreasing cost of sequencing are the major factors driving the growth of the SBS segment.

"APAC is projected to witness the highest growth during the forecast period "

While North America accounted for the largest share of the market in 2016, Asia-Pacific is expected to register the highest growth rate during the forecast period from 2017 to 2022. This is owing to increasing incidence of target diseases, rising awareness regarding the benefits of NGS-based clinical applications, and growing research activity in the region.

Breakdown of supply-side primary interviews: by company type, designation, and region:

  • By Company Type - Tier 1 -31%, Tier 2 -48% and Tier 3 -21%
  • By Designation - C level - 26%, Director level - 24%, Others - 50%
  • By Region - North America - 29%, Europe - 35%, APAC - 21%, RoW - 15%

As of 2016, major players operating in the global NGS services market are BGI (China), Eurofins Scientific SE (Luxembourg), PerkinElmer, Inc. (U.S.), QIAGEN (Germany), Macrogen Inc. (South Korea), GENEWIZ, Inc. (U.S.), Illumina, Inc. (U.S.), Novogene Corporation (China), and GATC Biotech AG (Germany) among others.

Research Coverage:

This report studies the NGS services market-based on type, technology, application, and end user. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total market. The report forecasts the revenue of market segments with respect to four main regions.

Reasons to Buy the Report:

This research focuses on various levels of analysis-competitive leadership analysis of 25 market players, and company profiles of top 15 market players-which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the NGS services market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on business strategies adopted by the major players in the NGS services market. The report analyzes the NGS services market-based on types, technology, application, end user, and region.
  • Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and product & service launches in the NGS services.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various NGS services across geographies.
  • Market Diversification: Exhaustive information about new NGS services, untapped geographies, recent developments, and investments in the NGS services market.
  • Competitive Assessment: In-depth assessment of market ranking, strategies, products and services, and sequencing capabilities of leading players in the NGS services market.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
    • 1.2.1. MARKETS COVERED
    • 1.2.2. YEARS CONSIDERED FOR THE STUDY
  • 1.3. CURRENCY
  • 1.4. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH APPROACH
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY DATA
      • 2.2.2.1. Breakdown of primaries
      • 2.2.2.2. Key data from primary sources
      • 2.2.2.3. Key industry insights
  • 2.3. MARKET SIZE ESTIMATION
    • 2.3.1. BOTTOM-UP APPROACH
    • 2.3.2. TOP-DOWN APPROACH
  • 2.4. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. NEXT-GENERATION SEQUENCING (NGS) SERVICES MARKET OVERVIEW
  • 4.2. GLOBAL NGS SERVICES MARKET, BY TYPE, 2015 VS. 2017 VS. 2022(USD MILLION)
  • 4.3. GEOGRAPHIC ANALYSIS: NGS SERVICES MARKET, BY TECHNOLOGY (2017)
  • 4.4. NGS SERVICES MARKET, BY APPLICATION
  • 4.5. GLOBAL NGS SERVICES MARKET, BY END USER, 2017 VS. 2022
  • 4.6. GEOGRAPHICAL SNAPSHOT OF THE NGS SERVICES MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Declining price of sequencing
      • 5.2.1.2. High cost of sequencing infrastructure
      • 5.2.1.3. Need for skilled professionals for efficient NGS sample preparation and analysis
      • 5.2.1.4. Sequencing services, the preferred option for NGS applications with low throughput requirements
      • 5.2.1.5. Technological advancements in the field of sequencing
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Installation of in-house sequencing facilities in hospitals and universities
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Analysis of complex sequencing data
      • 5.2.3.2. Increasing applications in cancer and agrigenomics research
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Accuracy & standardization concerns in diagnostic testing
      • 5.2.4.2. Ethical issues related to NIPT

6. GLOBAL NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY

  • 6.2. INTRODUCTION
  • 6.3. SEQUENCING BY SYNTHESIS
  • 6.4. ION SEMICONDUCTOR SEQUENCING
  • 6.5. SINGLE-MOLECULE REAL-TIME SEQUENCING
  • 6.6. NANOPORE SEQUENCING

7. GLOBAL NGS SERVICES MARKET, BY SERVICE TYPE

  • 7.1. INTRODUCTION
  • 7.2. TARGETED RESEQUENCING & CUSTOM GENE PANELS
  • 7.3. RNA-SEQ
  • 7.4. DE NOVO SEQUENCING
  • 7.5. EXOME SEQUENCING
  • 7.6. CHIP-SEQ
  • 7.7. WHOLE-GENOME SEQUENCING
  • 7.8. METHYL-SEQ
  • 7.9. OTHER SERVICES

8. NEXT-GENERATION SEQUENCING SERVICES MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. DIAGNOSTICS
    • 8.2.1. ONCOLOGY
    • 8.2.2. INFECTIOUS DISEASES
    • 8.2.3. RARE GENETIC DISORDERS
    • 8.2.4. REPRODUCTIVE HEALTH
    • 8.2.5. OTHER DIAGNOSTIC APPLICATIONS
  • 8.3. DRUG DISCOVERY
  • 8.4. BIOMARKER DISCOVERY
  • 8.5. AGRICULTURE & ANIMAL RESEARCH
  • 8.6. OTHER APPLICATIONS

9. NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER

  • 9.1. INTRODUCTION
    • 9.1.1. ACADEMIC & GOVERNMENT INSTITUTES AND RESEARCH CENTERS
    • 9.1.2. HOSPITALS & CLINICS
    • 9.1.3. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 9.1.4. OTHER END USERS

10. GLOBAL NEXT-GENERATION SEQUENCING SERVICES MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. U.K.
    • 10.3.3. FRANCE
    • 10.3.4. REST OF EUROPE
  • 10.4. ASIA-PACIFIC
    • 10.4.1. CHINA
    • 10.4.2. JAPAN
    • 10.4.3. INDIA
    • 10.4.4. REST OF ASIA-PACIFIC
  • 10.5. REST OF THE WORLD

11. COMPETITIVE LANDSCAPE

  • 11.1. INTRODUCTION
  • 11.2. MARKET RANKING ANALYSIS
  • 11.3. COMPETITIVE LEADERSHIP BENCHMARKING
    • 11.3.1. VISIONARY LEADERS
    • 11.3.2. INNOVATORS
    • 11.3.3. DYNAMIC DIFFERENTIATORS
    • 11.3.4. EMERGING COMPANIES
  • 11.4. STRENGTH OF PRODUCT PORTFOLIO (FOR 25 PLAYERS)
  • 11.5. BUSINESS STRATEGY EXCELLENCE (FOR 25 PLAYERS)

Top 25 companies analyzed for this study are - Illumina, Inc., BGI, Eurofins Scientific SE, PerkinElmer, Inc., QIAGEN N.V., GATC Biotech AG, Macrogen Inc., DNA Link, Inc, Genotypic Technology Pvt Ltd, WuXi AppTec, GENEWIZ, Inc., Takara Bio Inc., SciGenom Labs Pvt. Ltd, Theragen Etex Co., Ltd., LGC Genomics Limited, Oxford Gene Technology, Sysmex Corporation, Genomics BioSci & Tech. Co., Ltd., Zymo Research Corp, Source BioScience, IntegraGen SA, CENTOGENE AG, Otogenetics Corporation, Novogene Corporation, Personalis, Inc.

12. COMPANY PROFILES (OVERVIEW, PRODUCTS OFFERED, STRENGTH OF PRODUCT PORTFOLIO, BUSINESS STRATEGY EXCELLENCE, RECENT DEVELOPMENTS.)*

  • 12.1. INTRODUCTION
  • 12.2. BGI
  • 12.3. ILLUMINA, INC.
  • 12.4. PERKINELMER, INC.
  • 12.5. EUROFINS SCIENTIFIC SE
  • 12.6. GATC BIOTECH AG
  • 12.7. MACROGEN, INC.
  • 12.8. QIAGEN N.V.
  • 12.9. GENOTYPIC TECHNOLOGY PVT. LTD.
  • 12.10. GENEWIZ, INC.
  • 12.11. DNA LINK, INC.
  • 12.12. TAKARA BIO INC. (PART OF TAKARA HOLDING COMPANY INC.)
  • 12.13. SCIGENOM LABS PVT. LTD
  • 12.14. NOVOGENE CORPORATION
  • 12.15. PERSONALIS, INC.
  • 12.16. LGC LIMITED (A PART OF KKR & CO. L.P.)

*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key relationships might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. DISCUSSION GUIDE
  • 13.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.4. AVAILABLE CUSTOMIZATIONS
  • 13.5. RELATED REPORTS
  • 13.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: NGS SERVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 2: NGS SERVICES MARKET FOR SEQUENCING BY SYNTHESIS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 3: NGS SERVICES MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 4: NGS SERVICES MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 5: NGS SERVICES MARKET FOR NANOPORE SEQUENCING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: NGS SERVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 7: TARGETED SEQUENCING SERVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: RNA-SEQ SERVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 9: DE NOVO SEQUENCING SERVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: EXOME SEQUENCING SERVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: CHIP-SEQ SERVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 12: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: METHYL-SEQ SERVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 14: OTHER NGS SERVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 16: NGS DIAGNOSTIC SERVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 17: NEXT-GENERATION SEQUENCING SERVICES MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: NEXT-GENERATION SEQUENCING SERVICES MARKET FOR DRUG DISCOVERY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: NEXT-GENERATION SEQUENCING SERVICES MARKET FOR BIOMARKER DISCOVERY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: NEXT-GENERATION SEQUENCING SERVICES MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 21: NEXT-GENERATION SEQUENCING SERVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 22: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 23: NEXT-GENERATION SEQUENCING SERVICES MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES AND RESEARCH CENTERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 24: NEXT-GENERATION SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 25: NEXT-GENERATION SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 26: NEXT-GENERATION SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 27: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 28: NORTH AMERICA: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 29: NORTH AMERICA: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 30: NORTH AMERICA: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 31: NORTH AMERICA: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 32: NORTH AMERICA: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 33: U.S.: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 34: CANADA: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 35: EUROPE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 36: EUROPE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 37: EUROPE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 38: EUROPE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 39: EUROPE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 40: GERMANY: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 41: U.K.: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 42: FRANCE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 43: ROE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 44: ASIA-PACIFIC: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 45: ASIA-PACIFIC: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 46: ASIA-PACIFIC: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 47: ASIA-PACIFIC: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 48: ASIA-PACIFIC: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 49: CHINA: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 50: JAPAN: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 51: INDIA: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 52: ROAPAC: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 53: ROW: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 54: ROW: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 55: ROW: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 56: ROW: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: GLOBAL NGS SERVICES MARKET: RESEARCH APPROACH
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: NGS SERVICES MARKET: BOTTOM-UP APPROACH
  • FIGURE 5: NGS SERVICES MARKET: TOP-DOWN APPROACH
  • FIGURE 6: NGS SERVICES MARKET: DATA TRIANGULATION
  • FIGURE 7: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2017 VS. 2022
  • FIGURE 8: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2017 VS. 2022 (USD MILLION)
  • FIGURE 9: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY APPLICATION, 2017 VS. 2022 (USD MILLION)
  • FIGURE 10: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER, 2017 VS. 2022 (USD MILLION)
  • FIGURE 11: GEOGRAPHICAL SNAPSHOT OF THE NEXT-GENERATION SEQUENCING SERVICES MARKET
  • FIGURE 12: INCREASING APPLICATIONS OF NGS IN CANCER AND AGRIGENOMICS RESEARCH TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD
  • FIGURE 13: NORTH AMERICA TO DOMINATE THE NGS SERVICES MARKET IN 2017
  • FIGURE 14: AGRICULTURE & ANIMAL RESEARCH SEGMENT TO REGISTER THE HIGHEST GROWTH RATE IN THE NGS SERVICES MARKET BETWEEN 2017 & 2022
  • FIGURE 15: ACADEMIC & GOVERNMENT INSTITUTES AND RESEARCH CENTERS SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL NGS SERVICES MARKET IN 2022
  • FIGURE 16: ASIA-PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 17: NEXT-GENERATION SEQUENCING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18: HUMAN WHOLE-GENOME SEQUENCING COST ESTIMATED BY THE NATIONAL HUMAN GENOME RESEARCH INSTITUTE
  • FIGURE 19: NANOPORE SEQUENCING TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2017 TO 2022)
  • FIGURE 20: NGS SERVICES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • FIGURE 21: TARGETED RESEQUENCING/CUSTOM GENE PANELS SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL NEXT-GENERATION SEQUENCING SERVICES MARKET IN 2022
  • FIGURE 22: DIAGNOSTICS SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL NEXT-GENERATION SEQUENCING SERVICES MARKET IN 2022
  • FIGURE 23: GROWTH IN NUMBER OF GENETIC TESTS (2012-2016)
  • FIGURE 24: INCREASING PUBLICATIONS RELATED TO BIOMARKER DISCOVERY BASED ON NGS DURING 2011-2016
  • FIGURE 25: ACADEMIC & GOVERNMENT INSTITUTES AND RESEARCH CENTERS TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 26: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY REGION
  • FIGURE 27: NORTH AMERICA: NEXT-GENERATION SEQUENCING SERVICES MARKET SNAPSHOT
  • FIGURE 28: EUROPE: NEXT-GENERATION SEQUENCING SERVICES MARKET SNAPSHOT
  • FIGURE 29: ASIA-PACIFIC: NEXT-GENERATION SEQUENCING SERVICES MARKET SNAPSHOT
  • FIGURE 30: ROW: NEXT-GENERATION SEQUENCING SERVICES MARKET SNAPSHOT
  • FIGURE 31: BGI, EUROFINS SCIENTIFIC SE, AND MACROGEN WERE THE LEADING PROVIDERS FOR NGS SERVICES WORLDWIDE IN 2016
  • FIGURE 32: NGS SERVICES MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2017
  • FIGURE 33: ILLUMINA, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 34: PERKINELMER, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 35: EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2016)
  • FIGURE 36: MACROGEN, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 37: QIAGEN N.V.: COMPANY SNAPSHOT (2016)
  • FIGURE 38: TAKARA BIO INC.: COMPANY SNAPSHOT (2016)
Back to Top